SUMOylation Alterations Are Associated With Multidrug Resistance in Hepatocellular Carcinoma

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2014.1882
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Shp2 SUMOylation Promotes ERK Activation and Hepatocellular Carcinoma Development

Oncotarget
Oncology
2015English

Expression of Multidrug Resistance-Associated Protein 2 in Human Gallbladder Carcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Elevated Serum Visfatin Levels Are Associated With Poor Prognosis of Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Exosomal microRNA-32-5p Induces Multidrug Resistance in Hepatocellular Carcinoma via the PI3K/Akt Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Pro: Direct-Acting Agents Are Associated With Occurrence and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

ACTG1 and TLR3 Are Biomarkers for Alcohol‑associated Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Polymorphisms in MicroRNA Target Sites of Forkhead Box O Genes Are Associated With Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2015English

Small Hepatocellular Carcinoma Associated With Wilson’s Disease

Internal Medicine
Internal MedicineMedicine
2005English

Genetic Variations of NTCP Are Associated With Susceptibility to HBV Infection and Related Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy